Replies to post #512421 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

fine by us, you can move on then. no reason to spam our page

[Doc logic]

HyGro,

If you can’t tell me why macrophage infiltration has often been a problem after treatment with L in this trial but is much less of a problem with properly administered L with adjuvants or in combo with certain checkpoint inhibitors or Direct, then your opinion about NWBO as an investment really isn’t capturing the value of the science which is in line with your conclusion. I have been invested long since 2012 and already have significant gains because of cost averaging down during all this time. This is also my only biotech holding and has been for years. If you haven’t figured it out by now, some of us have just been waiting all this time for the formal validation of the science once commercial scale manufacturing for a new SOC in GBM, rGBM and probably lower grade gliomas soon after had a chance to catch up. This platform will reach quickly into label extensions and Direct and or an L/Direct synergistic combo will completely change cancer treatment. Big picture HyGro, you should have been looking at the big picture. Best wishes.

[Idunno]

Lol. … Okay, Hygro, purely hypothetically, I’m curious: if some entity offered you, oh, two million dollars, to ‘splain yourself, if you know what I mean, would you take them up on it? Idle here. Just killin time on my end. Yes, or no. And, no one would ever have to know. ….

[biosectinvestor]

Yeah, sure. That sounds completely feasible.

[Roman516]

Wonderful to hear that your investment in the magnetic flux device paid off, IMO. Sad to hear about your investigation issues with NWBO. However, there still appears to be a major confounding issue resulting in missing the facts that DCVax-L works. Many intelligent individuals already know that there are ample number of doctors, scientist, and professionals who agree with the data, and they are impressed with the DCVax-L data results. So, if you don't like what you see, then move on and focus on other investments. As a research scientist, I have spent considerable time and effort reviewing NWBO's data, the Flaskworks device, several of the detailed manufacturing processes, multiple partnership capabilities, and my analysis points to the fact that NWBO is on the right path. BWT, I have spent over 35 years working with multiple regulatory agencies and facilities involving a vast array of products, and it certainly appears that the Sawston, UK facility is on the right path. In addition, the University of Cambridge and Kings College are very competent schools that are also involved with the entire DCVax-L manufacturing processes. Looking forward to regulatory acceptance based on the true data, the true facts, the advanced automated manufacturing process, the adaptive manufacturing capabilities, and a host of very competent individuals who have the necessary skills and expertise to help NWBO proceed forward, IMPO.